The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Abstract
Drugs of abuse are very powerful reinforcers, and even in conditions of limited access (where the organism is not dependent) these drugs will motivate high rates of operant responding. This presumed hedonic property and the drugs' neuropharmacological specificity provide a means of studying the neuropharmacology and neuroanatomy of brain reward. Three major brain systems appear to be involved in drug reward--dopamine, opioid and GABA. Evidence suggests a midbrain-forebrain-extrapyramidal circuit with its focus in the nucleus accumbens. Data implicating dopamine and opioid systems in indirect sympathomimetic and opiate reward include critical elements in both the nucleus accumbens and ventral tegmental areas. Ethanol reward appears to depend on an interaction with the GABAA receptor complex but may also involve common elements such as dopamine and opioid peptides in this midbrain-forebrain-extrapyramidal circuit. These results suggest that brain reward systems have a multidetermined neuropharmacological basis that may involve some common neuroanatomical elements.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, there is extensive experimental evidence in animal contexts supporting a role for the mesolimbic reward pathway on appetitive and motivational behaviors [306,307].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [307]
In the citing paper
“The meso-limbic dopamine system that projects from the ventral tegmental area (VTA) to the nucleus accumbens has been implicated in the rewarding effects of drugs of abuse”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Koob, 1992
Citations
Cites
Handbook of Psychopharmacology
Iversen, L. L., Iversen, S. D., & Snyder, S. H. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,756
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationWise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Fallon, J. H., & Moore, R. Y. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901800310 · Cited by 1,190
Mesocorticolimbic dopaminergic network: functional and regulatory roles
Moal, M. L., & Simon, H. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.155 · Cited by 1,108
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Research works printed but not linked: 21
- Dahlström, 1964, Acta Physiol. Scand., 232, 1
- Weiss, F. et al.Ann. NY Acad. Sci. (in press).
- Pfeffer, 1985, Alcohol Drug Res., 6, 37
- Rassnick, S., Pulvirenti, L. and Koob, G. F. Psychopharmacology (in press).
- Samson, 1988, Alcohol. Clin. Exp. Res., 12, 581
- Imperato, 1986, J. Pharmacol. Exp. Ther., 239, 221
- Bodnar, 1990, Crit. Rev. Neurobiol., 6, 39
- West, 1989, Soc. Neurosri. Abstr., 15, 20.8
- Koob, 1984, J. Pharmacol. Exp. Ther., 229, 481
- Goldberg, 1971, J. Pharmacol. Exp. Ther., 176, 464
- Di Chiara, 1988, J. Pharmacol. Exp. Ther., 244, 1067
- Di Chiara, 1988, 85, 5274
- Shippenberg, T. S., Spanagel, R. and Herz, A.Ann. NY Acad. Sci. (in press).
- Givens, 1990, J. Pharmacol. Exp. Ther., 254, 528
- Sepinwall, 1978, Vol. 13, 345
- Koob, G. F. and Britton, K. T. in Pharmacology and Neuropharmacology (Vol. 2) Alcohol and Alcoholisms (Begleiter, H. and Kissin, B., eds), Oxford University Press (in press).
- Frye, 1982, J. Pharmacol. Exp. Ther., 223, 750
- Suzdak, 1986, 83, 4071
- Rassnick, S. et al.Ann. NY Acad. Sci. (in press).
- Deitrich, 1989, Pharmacol. Rev., 41, 489
- Pickens, 1981, J. Pharmacol. Exp. Ther., 216, 205
Cited by
Sorted by citations
Items 901–1,000 of 1,004
Rønnekleiv, O. K., Bosch, M. A., Cunningham, M. J., Wagner, E. J., Grandy, D. K., & Kelly, M. J. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)13033-0 · Cited by 43
Nalmefene for the treatment of alcohol dependence: a current update
Soyka, M. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001284 · Cited by 42
Jensen, M. E., Galli, A., Thomsen, M., Jensen, K. L., Thomsen, G. K., Klausen, M. K., Vilsbøll, T., Christensen, M., Holst, J. J., Owens, A. W., et al. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104772 · Cited by 42
Nuutinen, S., Kononoff, J., Pigni, M. C., & Panula, P. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.027 · Cited by 42
Rahman, S., & McBride, W. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00326.x · Cited by 42
Effects of chronic food restriction on prodynorphin-derived peptides in rat brain regions
Berman, Y. L., Devi, L. A., & Carr, K. D. (1994) · Brain Research · doi:10.1016/0006-8993(94)91952-6 · Cited by 42
Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation
Azaryan, A. V., Clock, B. J., & Cox, B. M. (1996) · Neurochemical Research · doi:10.1007/bf02532382 · Cited by 42
Sahraei, H., Ghazzaghi, H., Zarrindast, M., Ghoshooni, H., Sepehri, H., & Haeri-Rohan, A. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.03.004 · Cited by 42
Zarrindast, M., Gholami, A., Sahraei, H., & Haeri-Rohani, A. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.006 · Cited by 42
Chick, J., & Erickson, C. K. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01658.x · Cited by 42
Transgenic mice in drug dependence research
Pich, E. M., & Epping-Jordan, M. P. (1998) · Annals of Medicine · doi:10.3109/07853899809029939 · Cited by 42
Immunohistochemical studies of mesolimbic dopaminergic neurons in Fischer 344 and Lewis rats
Harris, H. W., & Nestler, E. J. (1996) · Brain Research · doi:10.1016/0006-8993(95)01088-2 · Cited by 42
Modulation of cellular activity and synaptic transmission in the ventral tegmental area
Mathon, D. S., Kamal, A., Smidt, M. P., & Ramakers, G. M. J. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.097 · Cited by 41
Nicotinic Activation of Laterodorsal Tegmental Neurons: Implications for Addiction to Nicotine
Ishibashi, M., Leonard, C. S., & Kohlmeier, K. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.82 · Cited by 41
Suppressive effects of milk-derived lactoferrin on psychological stress in adult rats
Kamemori, N., Takeuchi, T., Hayashida, K., & Harada, E. (2004) · Brain Research · doi:10.1016/j.brainres.2004.09.015 · Cited by 41
Amiri, S., Alijanpour, S., Tirgar, F., Haj‐Mirzaian, A., Amini-Khoei, H., Rahimi-Balaei, M., Rastegar, M., Ghaderi, M., Ghazi‐Khansari, M., & Zarrindast, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.003 · Cited by 41
Opioid receptor modulation of feeding-evoked dopamine release in the rat nucleus accumbens
Taber, M. T., Zernig, G., & Fibiger, H. C. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01124-4 · Cited by 41
Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats
Foll, B. L., Wertheim, C. E., & Goldberg, S. R. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.07.074 · Cited by 41
Mochizuki, T., Kim, J., & Sasaki, K. (2010) · Peptides · doi:10.1016/j.peptides.2010.02.006 · Cited by 41
Peripheral involvement in nicotine-induced enhancement of ethanol intake
Ericson, M., Engel, J. A., & Söderpalm, B. (2000) · Alcohol · doi:10.1016/s0741-8329(99)00099-3 · Cited by 41
Pacchioni, A. M., Gabriele, A., & See, R. E. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.12.014 · Cited by 41
Carey, R. J., & Gui, J. (1997) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(96)02203-0 · Cited by 41
Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice
Carrigan, K. A., & Dykstra, L. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0671-1 · Cited by 41
Chevrette, J., Stellar, J. R., Hesse, G. W., & Markou, A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00686-4 · Cited by 41
Systemic morphine and local opioid effects on neuronal activity in the medial prefrontal cortex
Giacchino, J. L., & Henriksen, S. J. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00409-2 · Cited by 41
Darracq, L., Drouin, C., Blanc, G., Glowinski, J., & Tassin, J. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00578-9 · Cited by 41
Genetic, sex, and early environmental effects on the voluntary alcohol intake in Wistar rats
Sluyter, F., Hof, M., Ellenbroek, B. A., Degen, S. B., & Cools, A. R. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00425-1 · Cited by 41
Reduced dopaminergic function in alcoholics is related to severe dependence
Schmidt, L. G., Dettling, M., Graef, K.-J., Heinz, A., Kühn, S., Podschus, J., & Rommelspacher, H. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00078-x · Cited by 41
Wu, X.-H., & Gu, H. H. (1999) · Gene · doi:10.1016/s0378-1119(99)00143-2 · Cited by 41
Drug Dependence, Synaptic Plasticity, and Tissue Plasminogen Activator
Yamada, K., Nagai, T., & Nabeshima, T. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cp0040014 · Cited by 41
Carey, R. J., & Damianopoulos, E. N. (1994) · Behavioural Brain Research · doi:10.1016/0166-4328(94)90026-4 · Cited by 41
Neurochemical and behavioural interactions between ibogaine and nicotine in the rat
Benwell, M. E. M., Holtom, P. E., Moran, R. J., & Balfour, D. J. K. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15253.x · Cited by 41
Anooshe, M., Nouri, K., Karimi‐Haghighi, S., Mousavi, Z., & Haghparast, A. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113158 · Cited by 40
Alcoholism risk, tobacco smoking, and P300 event-related potential
Polich, J. M., & Ochoa, C. J. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.01.026 · Cited by 40
Suzuki, T., Nurrochmad, A., Masahiko, O., Khotib, J., Nakamura, A., Imai, S., Shibasaki, M., Yajima, Y., & Narita, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.009 · Cited by 40
Darbandi, N., Rezayof, A., & Zarrindast, M. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.04.001 · Cited by 40
Outcome Study of Kleptomania Patients Treated With Naltrexone
Grant, J. E. (2005) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000150868.06512.0b · Cited by 40
Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area
Mansvelder, H. D., Fagen, Z. M., Chang, B., Mitchum, R. D., & McGehee, D. S. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.034 · Cited by 40
Justinová, Z., Panlilio, L. V., & Goldberg, S. R. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_13 · Cited by 40
Wu, H., Sugihara, I., & Shinoda, Y. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990816)411:1 · Cited by 235
Martı́n, S., Lyupina, Y. V., Crespo, J. A., González, B., Garcı́a-Lecumberri, C., & Ambrosio, E. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02482-x · Cited by 40
Rada, P. V., Colasante, C., Skirzewski, M., Hernandez, L., & Hoebel, B. G. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.03.043 · Cited by 40
Cocaine Upregulates the Dopamine Transporter in Fetal Rhesus Monkey Brain
Fang, Y., & Rønnekleiv, O. K. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08966.1999 · Cited by 40
Crews, F. T., Miller, M. W., Ma, W., Nixon, K., Zawada, W. M., & Zakhari, S. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000052581.46630.c5 · Cited by 40
Wang, D., Surratt, C. K., & Sadée, W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750763.x · Cited by 40
Neurobiological mechanisms and related clinical treatment of addiction: a review
Fang, Y., Sun, Y., Liu, Y., Liu, T., Hao, W., & Liao, Y. (2022) · Psychoradiology · doi:10.1093/psyrad/kkac021 · Cited by 39
Baracz, S. J., Everett, N. A., & Cornish, J. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136132 · Cited by 39
Baladi, M. G., Daws, L. C., & France, C. P. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.005 · Cited by 39
Hack, L. M., Kalsi, G., Alıev, F., Kuo, P., Prescott, C. A., Patterson, D. G., Walsh, D., Dick, D. M., Riley, B. P., & Kendler, K. S. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01353.x · Cited by 39
Cocaine, Hormones, and Behavior: Clinical and Preclinical Studies
Mello, N. K., & Mendelson, J. H. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00098-x · Cited by 39
Schmitz, J. (2005) · Sexual Addiction & Compulsivity The Journal of Treatment and Prevention · doi:10.1080/10720160500203641 · Cited by 39
Neuropeptides: implications for alcoholism
Cowen, M. S., Chen, F., & Lawrence, A. J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02394.x · Cited by 39
Dopamine D3receptor ligands for the treatment of tobacco dependence
Foll, B. L., Goldberg, S. R., & Sokoloff, P. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.45 · Cited by 39
Kindlundh, A. M. S., Bergström, M., Monazzam, A., Hallberg, M., Blomqvist, G., Långström, B., & Nyberg, F. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00293-2 · Cited by 39
Intra-accumbal CB1 receptor blockade reduced extinction and reinstatement of morphine
Khaleghzadeh‐Ahangar, H., & Haghparast, A. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.06.005 · Cited by 39
Lindblom, J., Kask, A., Hägg, E., Härmark, L., Bergström, L., & Wikberg, J. E. S. (2002) · Pharmacological Research · doi:10.1006/phrs.2001.0913 · Cited by 39
Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice
Rasmussen, T., Sauerberg, P., Nielsen, E. B., Swedberg, M. D. B., Thomsen, C., Sheardown, M. J., Jeppesen, L., Calligaro, D. O., DeLapp, N. W., Whitesitt, C. A., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00442-8 · Cited by 39
Narita, M., Miyagawa, K., Mizuo, K., Yoshida, T., & Suzuki, T. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00048.x · Cited by 39
Serotonin3 Receptor Antagonism of Alcohol Intake: Effects of Drinking Conditions
McKinzie, D. L., Eha, R. D., Cox, R., Stewart, R. B., Dyr, W., Murphy, J. M., McBride, W. J., Lumeng, L., & Tk, L. (1998) · Alcohol · doi:10.1016/s0741-8329(97)00132-8 · Cited by 39
Geijer, T., Jönsson, E. G., Neiman, J., Person, M. ‐., Brené, S., Gyllander, A., Sedvall, G., Rydberg, U. S., Wasserman, D., & Terenius, L. Y. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199702000-00005 · Cited by 39
Rauf, K., Subhan, F., & Sewell, R. D. E. (2011) · Phytotherapy Research · doi:10.1002/ptr.3631 · Cited by 38
Neurobiology of drug addiction.
Koob, G. F., Caine, S. B., Hyytiä, P., Markou, A., Parsons, L. H., Roberts, A. J., Schulteis, G., & Weiss, F. (1999) · American Psychological Association eBooks · doi:10.1037/10341-008 · Cited by 38
Self-citationDeurwaerdère, P. D., Lagière, M., Bosc, M., & Navailles, S. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3508-2 · Cited by 38
Perplexities and provocations of eating disorders
Halmi, K. A. (2009) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.01983.x · Cited by 38
Estrogen signaling in hypothalamic circuits controling reproduction
Kelly, M. J., & Qiu, J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.082 · Cited by 38
Johnson, B. A. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.9.1943 · Cited by 38
Yan, Q. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00699-8 · Cited by 38
Braun, A. A., Amos‐Kroohs, R. M., Gutierrez, A., Lundgren, K. H., Seroogy, K. B., Vorhees, C. V., & Williams, M. T. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9616-6 · Cited by 38
Betancur, C., Rostène, W. H., & Bérod, A. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00289-6 · Cited by 38
Cohen, C., Perrault, G., & Sanger, D. J. (1999) · Psychopharmacology · doi:10.1007/s002130050868 · Cited by 38
Maldonado, C., Cauli, O., Rodríguez‐Arias, M., Aguilar, M. A., & Miñarro, J. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00044-5 · Cited by 38
Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice
Borgkvist, A., Puelles, E., Carta, M., Acampora, D., Ang, S., Wurst, W., Goiny, M., Fisone, G., Simeone, A., & Usiello, A. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.09.018 · Cited by 38
Carey, R. J. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00253-4 · Cited by 38
Gerrits, M. A. F. M., Wiegant, V. M., & van Ree, J. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00336-4 · Cited by 38
Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats
McMillen, B. A., Jones, E. A., Hill, L. J., Williams, H. L., Björk, A., & Myers, R. D. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90327-p · Cited by 38
Safety and Efficacy of Acamprosate for the Treatment of Alcohol Dependence
Yahn, S. L., Watterson, L. R., & Olive, M. F. (2013) · Substance Abuse Research and Treatment · doi:10.4137/sart.s9345 · Cited by 37
Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential
Soyka, M. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1146689 · Cited by 37
Karoly, H. C., Mueller, R. L., Bidwell, L. C., & Hutchison, K. E. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14256 · Cited by 37
Diaz, S. L., Barros, V. G., Antonelli, M. C., Rubio‐Terres, C., & Balerio, G. N. (2006) · Synapse · doi:10.1002/syn.20279 · Cited by 37
Methamphetamine-induced behavioral sensitization in mice: alterations in μ-opioid receptor
Chiu, C., Ma, T., & Ho, I. K. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-006-9102-x · Cited by 37
Moore, K., Madularu, D., Iriah, S. C., Yee, J. R., Kulkarni, P. P., Darcq, E., Kieffer, B. L., & Ferris, C. F. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00471 · Cited by 37
Bueno, A., Carvalho, F. B., Gutierres, J. M., Lhamas, C. L., & de Andrade, C. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177623 · Cited by 37
Menthol facilitates dopamine-releasing effect of nicotine in rat nucleus accumbens
Zhang, M., Harrison, E., Biswas, L., Tran, T., & Liu, X. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.09.004 · Cited by 37
Walker, Q. D., Schramm‐Sapyta, N. L., Caster, J. M., Waller, S. T., Brooks, M. P., & Kuhn, C. M. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.08.019 · Cited by 37
Merrer, J. L., Gavello-Baudy, S., Galey, D., & Cazala, P. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.014 · Cited by 37
ICV testosterone induces Fos in male Syrian hamster brain
DiMeo, A. N., & Wood, R. I. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.08.001 · Cited by 37
Johnson, B. A., Roache, J. D., Bordnick, P. S., & Ait‐Daoud, N. (1999) · Psychopharmacology · doi:10.1007/s002130051007 · Cited by 37
Desole, M. S., Esposito, G., Fresu, L. G., Migheli, R., Enrico, P., Mura, M. A., Natale, G. D., MIELE, E., & Miele, M. (1996) · Brain Research · doi:10.1016/0006-8993(96)00235-1 · Cited by 37
Huang, N., Tseng, C., Wong, C., & Tung, C. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00236-5 · Cited by 37
Nicotine causes age-dependent changes in gene expression in the adolescent female rat brain
Polesskaya, O. O., Fryxell, K. J., Merchant, A. D., Locklear, L. L., Ker, K.-F., McDonald, C. G., Eppolito, A. K., Smith, L. N., Wheeler, T. L., & Smith, R. F. (2007) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.11.005 · Cited by 36
Carrara‐Nascimento, P. F., Olive, M. F., & Camarini, R. (2012) · Developmental Psychobiology · doi:10.1002/dev.21089 · Cited by 36
Hirasawa-Fujita, M., Bly, M. J., Ellingrod, V. L., Dalack, G. W., & Domino, E. F. (2017) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/1935-1232-11.1.39 · Cited by 36
Schmidt, L. S., Miller, A. D., Lester, D. B., Bay-Richter, C., Schülein, C., Frikke‐Schmidt, H., Wess, J., Blaha, C. D., Woldbye, D. P. D., Fink‐Jensen, A., et al. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1685-2 · Cited by 36
Alvarez-Jaimes, L., Polis, I., & Parsons, L. H. (2009) · The Open Neuropsychopharmacology Journal · doi:10.2174/1876523800902020077 · Cited by 32
Tapering opioids: a comprehensive qualitative review
Davis, M. P., Digwood, G., Mehta, Z., & McPherson, M. L. (2020) · Annals of Palliative Medicine · doi:10.21037/apm.2019.12.10 · Cited by 33
Brett, R. R., & Pratt, J. A. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15083.x · Cited by 26
Stress as a Risk Factor for Substance Use Disorders: A Mini-Review of Molecular Mediators
Mukhara, D., Banks, M. L., & Neigh, G. N. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00309 · Cited by 26
The effects of naltrexone among alcohol non-abstainers: results from the COMBINE study
Ray, L. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00026 · Cited by 21
Matelli (1998) · doi:10.1002/(sici)1096-9861(19981221)402:3
Xiao (1998) · doi:10.1002/(sici)1098-2396(199808)29:4
Metadata
- Authors
- Koob, G. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Koob, George F.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 13
- Issue
- 5
- Pages
- 177-184
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2001865657
- Cited by
- 2,070
- References
- 73
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 17 · 2021: 28 · 2020: 30 · 2019: 28 · 2018: 46 · 2017: 42 · 2016: 43 · 2015: 37 · 2014: 58 · 2013: 53 · 2012: 53
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA-08459)
- National Institute on Drug Abuse (DA04043, DA04398, R01DA004398, R01DA004043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- drugs of abuse, brain reward system, dopamine, opioid system, GABA, nucleus accumbens, ventral tegmental area, ethanol reward, opioid reward, operant responding
- MeSH terms
- Animals, Brain, Humans, Reward, Illicit Drugs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review